Top

Published in:

01-08-2010 | Review Article

A systematic review of trismus induced by cancer therapies in head and neck cancer patients

Authors: Rene-Jean Bensadoun, Dorothea Riesenbeck, Peter B. Lockhart, Linda S. Elting, Fred K. L. Spijkervet, Mike T. Brennan, Trismus Section, Oral Care Study Group, Multinational Association for Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO)

Published in: Supportive Care in Cancer | Issue 8/2010

Abstract

Purpose

This systematic review represents a thorough evaluation of the literature to clarify the impact of cancer therapies on the prevalence, quality of life and economic impact, and management strategies for cancer-therapy-induced trismus.

Methods

A systematic literature search was conducted with assistance from a research librarian in the databases MEDLINE/PubMed and EMBASE for articles published between January 1, 1990 and December 31, 2008. Each study was independently assessed by two reviewers. Taking into account predetermined quality measures, a weighted prevalence was calculated for the prevalence of trismus. The level of evidence, recommendation grade, and guideline (if possible) were given for published preventive and management strategies for trismus.

Results

We reviewed a total of 22 published studies between 1990 and 2008. Most of them assessed the prevalence of this complication, and few focused on management. The weighted prevalence for trismus was 25.4% in patients who received conventional radiotherapy and 5% for the few intensity-modulated radiation therapy studies. No clear guideline recommendations could be made for the prevention or management of trismus.

Conclusions

Newer radiation modalities may decrease the prevalence of trismus compared to conventional radiotherapy. Few studies have addressed the quality of life impact of trismus, and no studies were identified to assess the economic impact of trismus. The few preventive and management trials identified in the literature showed some promise, although larger, well-designed studies are required to appropriately assess these therapies before recommendations can be provided.

Brennan MT, Spijkervet FKL, Elting LS (2010) Methodology review. Support Care Cancer (in press)

Chao CK, Ozyigit G, Blanco AI, Thorstad WL, Deasy JO, Haughey BH, Spector GJ, Sessions DG (2004) Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume. Int J Radiat Oncol Biol Phys 59:43–50PubMed

Chen AM, Bucci MK, Singer MI, Garcia J, Kaplan MJ, Chan AS, Phillips TL (2007) Intraoperative radiation therapy for recurrent head-and-neck cancer: the UCSF experience. Int J Radiat Oncol Biol Phys 67:122–129PubMed

Chua DT, Lo C, Yuen J, Foo YC (2001) A pilot study of pentoxifylline in the treatment of radiation-induced trismus. Am J Clin Oncol 24:366–369CrossRefPubMed

Daoud J, Toumi N, Bouaziz M, Ghorbel A, Jlidi R, Drira MM, Frikha M (2003) Nasopharyngeal carcinoma in childhood and adolescence: analysis of a series of 32 patients treated with combined chemotherapy and radiotherapy. Eur J Cancer 39:2349–2354CrossRefPubMed

Dijkstra PU, Huisman PM, Roodenburg JL (2006) Criteria for trismus in head and neck oncology. Int J Oral Maxillofac Surg 35:337–342CrossRefPubMed

Dijkstra PU, Kalk WW, Roodenburg JL (2004) Trismus in head and neck oncology: a systematic review. Oral Oncol 40:879–889CrossRefPubMed

Eisen MD, Weinstein GS, Chalian A, Machtay M, Kent K, Coia LR, Weber RS (2000) Morbidity after midline mandibulotomy and radiation therapy. Am J Otolaryngol 21:312–317CrossRefPubMed

Grandi G, Silva ML, Streit C, Wagner JC (2007) A mobilization regimen to prevent mandibular hypomobility in irradiated patients: an analysis and comparison of two techniques. Med Oral Patol Oral Cir Bucal 12:E105–E109PubMed

10.

Hartl DM, Cohen M, Juliéron M, Marandas P, Janot F, Bourhis J (2008) Botulinum toxin for radiation-induced facial pain and trismus. Otolaryngol Head Neck Surg 138:459–463CrossRefPubMed

11.

Hsiung CY, Huang EY, Ting HM, Huang HY (2008) Intensity-modulated radiotherapy for nasopharyngeal carcinoma: the reduction of radiation-induced trismus. Br J Radiol 81:809–814CrossRefPubMed

12.

Kent ML, Brennan MT, Noll JL, Fox PC, Burri SH, Hunter JC, Lockhart PB (2008) Radiation-induced trismus in head and neck cancer patients. Support Care Cancer 16:305–309CrossRef

13.

Keus RB, Pontvert D, Brunin F, Jaulerry BJP (1988) Result of irradiation in squamous cell carcinoma of the soft palate and uvula. Radiother Oncol 11:311–317CrossRefPubMed

14.

Laskin DM, Greene CS, Hylander WL (2006) Temporomandibular disorders: an evidence-based approach to diagnosis and treatment. Quintessence, Chicago

15.

Le Scodan R, Pommier R, Ardiet JM, Montbarbon X, Malet C, Favrel V, Zrounba P, Poupart M, Céruse P, Ferlay C, Clippe S (2005) Exclusive brachytherapy for T1 and T2 squamous cell carcinomas of the velotonsillar area: results in 44 patients. Int J Radiat Oncol Biol Phys 63:441–448PubMed

16.

Levendag P, Nijdam W, Noever I, Schmitz P, Van de Pol M, Sipkema D, Braat C, De Boer M, Jansen P (2004) Brachytherapy versus surgery in carcinoma of tonsillar fossa and/or soft palate: late adverse sequelae and performance status: can we be more selective and obtain better tissue sparing? Int J Radiat Oncol Biol Phys 59:713–724PubMed

17.

Melchers LJ, Van Weert E, Beurskens CH, Reintsema H, Slagter AP, Roodenburg JL, Dijkstra PU (2009) Exercise adherence in patients with trismus due to head and neck oncology: a qualitative study into the use of the Therabite. Int J Oral Maxillofac Surg 38:947–954CrossRefPubMed

18.

Palazzi M, Guzzo M, Bossi P, Tomatis S, Cerrotta A, Cantú G, Locati LD, Licitra L (2004) Regionally advanced nasopharyngeal carcinoma: long-term outcome after sequential chemotherapy and radiotherapy. Tumori 90:60–65PubMed

19.

Palazzi M, Guzzo M, Tomatis S, Cerrotta A, Potepan P, Quattrone P, Cantù G (2004) Improved outcome of nasopharyngeal carcinoma treated with conventional radiotherapy. Int J Radiat Oncol Biol Phys 60:1451–1458PubMed

20.

Peterson DE et al. Systematic Review Osteoradionecrosis (2010) Support Care Cancer (in press)

21.

Ozsaran Z, Yalman D, Baltalarli B, Anacak Y, Esassolak M, Haydaroğlu A (2003) Radiotherapy in maxillary sinus carcinomas: evaluation of 79 cases. Rhinology 41:44–48PubMed

22.

Shulman DH, Shipman B, Willis FB (2008) Treating trismus with dynamic splinting: a cohort, case series. Adv Ther 25:9–15CrossRefPubMed

23.

Sultanem K, Shu HK, Xia P, Akazawa C, Quivey JM, Verhey LJ, Fu KK (2000) Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University Of California—San Francisco experience. Int J Radiat Oncol Biol Phys 48:711–722PubMed

24.

Teguh DN, Levendag PC, Voet P, van der Est H, Noever I, de Kruijf W, van Rooij P, Schmitz PI, Heijmen BJ (2008) Trismus in patients with oropharyngeal cancer: relationship with dose in structures of mastication apparatus. Head Neck 30:622–630CrossRefPubMed

25.

Wang CJ, Huang EY, Hsu HC, Chen HC, Fang FM, Hsiung CY (2005) The degree and time-course assessment of radiation-induced trismus occurring after radiotherapy for nasopharyngeal cancer. Laryngoscope 115:1458–1460CrossRefPubMed

26.

Wu Y, Hu WH, Xia YF, Ma J, Liu MZ, Cui NJ (2007) Quality of life of nasopharyngeal carcinoma survivors in Mainland China. Qual Life Res 16:65–74CrossRefPubMed

27.

Yeh SA, Tang Y, Lui CC, Huang YJ, Huang EY (2005) Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone. Int J Radiat Oncol Biol Phys 62:672–679PubMed

28.

NCI (1990) National Institutes of Health Consensus Development Conference on Oral Complications of Cancer Therapies: Diagnosis, Prevention, and Treatment. Bethesda, Maryland, April 17–19, 1989. NCI Monogr 9:1–184

Title: A systematic review of trismus induced by cancer therapies in head and neck cancer patients
Authors: Rene-Jean Bensadoun
Dorothea Riesenbeck
Peter B. Lockhart
Linda S. Elting
Fred K. L. Spijkervet
Mike T. Brennan
Trismus Section, Oral Care Study Group, Multinational Association for Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO)
Publication date: 01-08-2010
Publisher: Springer-Verlag
Published in: Supportive Care in Cancer / Issue 8/2010
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-010-0847-4

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 8/2010

A systematic review of orofacial pain in patients receiving cancer therapy

A systematic review of bisphosphonate osteonecrosis (BON) in cancer

Psychological well-being in a cohort of women with invasive breast cancer nearly 2 years after diagnosis

Erratum to: Psychosocial distress in acute cancer patients assessed with an expert rating scale

Osteoradionecrosis in cancer patients: the evidence base for treatment-dependent frequency, current management strategies, and future studies

Ranked importance of outcomes of first-line versus repeated chemotherapy among ovarian cancer patients

Keynote webinar | Spotlight on antibody–drug conjugates in cancer